Latest Conference Articles

Phase 3 trials continue to investigate the efficacy of EpiSmart, a new method of cross-linking that could be utilized in the treatment of keratoconus.

Kourtney Houser, MD, and Kendall Donaldson, MD, MS, give an overview of the important role topography and tomography play in catching keratoconus early in their patients.

Annual follow-ups for patients with keratoconus can help them become better candidates for cross-linking procedures, according to William Trattler, MD.

Shelley Cutler, OD, FAAO, comments on technological advancements leading to the progression of keratoconus diagnosis and treatment options during this year's IKA symposium.

Edmund Tsui, MD, details findings from a study that suggests that swept-source anterior segment OCT images by provide more objective ways to measure inflammation in the eye.

Michael Chaglasian, OD, details results from a study that assessed the new Monaco OCT's efficacy in glaucoma detection alongside ultra wideview imaging.

The microemulsion drug ocular penetration system platform technology was found to effectively formulate and deliver lipophilic molecules via topical eye drops.

Emily Chew, MD, who won this year's Proctor Award, outlines her presentation on preparing for estimated doubling of age-related macular degeneration cases in the next 25 years at ARVO 2024.

Noel Brennan, MScOptom, PhD, overviews his ARVO 2024 presentation on reimagining the prediction of longer term efficacy numbers in data from pediatric trials evaluating myopia.

Ricardo Pintor, OD, FIACLE, gives an overview of the World Council of Optometry’s first Latin America–based virtual event and what challenges Latin America faces in terms of myopia.

Osamah Saeedi, MD, MS, details his ARVO 2024 presentation and the study finding's implications on monitoring and treating glaucoma.

The 2 FDA registration trials for perfluorohexyloctane resulted in scientifically significant results for improvement of mild and moderate symptoms of dry eye disease.

Neda Gioia, OD, CNS, FOWNS, CFMP, details recent findings on the efficacy of the NutriTears supplement on dry eye symptoms.

Inder Paul Singh, MD, defines what it means to have an interventional mindset when it comes to glaucoma procedures and treatments during the Controversies in Modern Eye Care 2024 meeting.

Investigators recruited children with CVI and normal controls who were between the ages of 12 months and 12 years. They concluded that children with CVI have markedly lower VS-QOL compared to typically developing children.

Kelsey Roelofs, MD, gives her best methods to identifying and diagnosing thyroid eye disease in her Controversies in Modern Eye Care 2024 presentation.

Mary Beth Yackey, OD, and Michael Javaheri, MD, share their perspectives on the modernization of geographic atrophy identification and treatment.

Deborah Ristvedt, DO, details her CIME 2024 presentation on new glaucoma management options, led alongside Inder Paul Singh, MD, Arsham Sheybani, MD, and Melissa Tawa, OD, FAAO.

CIME Cochair Neda Shamie, MD, gives an overview of presentations on Demodex blepharitis, LASIK, retina sessions, and more at this year's conference.

Older age and longer duration of type 1 diabetes also play a role in the development of diabetic retinopathy, according to a chart review.

This study also found that upon discontinuation, myopia development did not rebound, with NVK002 0.01% as a potential long-term treatment for pediatric myopia.

David A. Berntsen, OD, PhD, FAAO, talks through his 2024 ARVO presentation on the BLINK2 study and the findings on axial growth after discontinuing soft multifocal contact lens wear.

The investigators induced experimental autoimmune encephalomyelitis in 15 female mice by immunizing them with myelin oligodendrocyte glycoprotein 33-55 in complete Freund’s adjuvant and pertussis toxin.

Arjan Hura, MD, gives an overview on a captivating retina panel and other enticing items at the CIME 2024 meeting.

James A Katz, MD, details treatment options for Demodex blepharitis, from tea tree oil to XDEMVY.

The Patient Whisperers Cofounders Lauren Weaver and Christine Scarlett gave their keynote presentation "The Secret to Crazy Growth: Defining Your Identity on Social Media," at the 2024 Controversies in Modern Eye Care meeting May 4 in Los Angeles, California.

The collective enhances education, research, and quality of life.

Neda Shamie, MD, previews a collaborative day packed with guest speakers, discussions on advanced patient care, and hands-on labs.